eli lilly retatrutide trial Lilly's triple agonist achieves 16.8% weight loss in phase 3 Eli Lilly's Retatrutide Delivers Bariatric-Style

In this episode, I share how GLP-1 weight loss transformed not only my health, labs, and medications, but also my relationship with my physician

This session addresses the following IPEC Competencies: Roles and Responsibilities, Interprofessional Communication

Continuous variables were expressed as medians (interquartile range, IQR) when nonnormally distributed, and they were the mean standard deviation (SD) when normally distributed

Glutathione may exert a limited effect in patients already on a medication regimen that harnesses anti-inflammatory pathways

Our team at California Infusion Centers answers the most common questions about this powerful antioxidant treatment